2026 Pittsburgh International Lung Conference-The Evolving Landscape of COPD: Bridging New Mechanisms and Emerging Therapies

September 17, 2026 to September 18, 2026

The 2026 Pittsburgh International Lung Conference (PILC) will have a specific focus on "The Evolving Landscape of COPD: Bridging New Mechanisms and Emerging Therapies".  COPD is a leading cause of death worldwide and overcoming challenges in COPD requires multidisciplinary cooperation across multiple fields, including basic and translational science, epidemiology, genetics, bioengineering, computational biology, and clinical research and implementation. The two-day program will include a keynote, seven main sessions covering topics such as the exposome, gene-to-function studies, regenerative medicine, aging, immunity, diagnostics, comorbidities, and biologics, plus a special session on AI. Interspaced with these sessions will be panel discussions, poster sessions, and an evening reception with a lecture by guest speaker, Steven D. Shapiro, MD.

Target Audience

Nurse
Nurse Practitioner
Pharmacist
Pharmacy Technician
Physician
Physician Assistant
Respiratory Therapists
Clinical Research Coordinators
Medical Residents
Public Health Experts

Learning Objectives

1) Demonstrate translation of scientific advances to clinical medicine in COPD.
2) Recognize the gaps in knowledge present in COPD pathogenesis including lung regeneration and how hallmarks aging relate to key biological process in COPD.
3) Expand knowledge of the therapeutic landscape in COPD and future in clinical trials.

Course summary

Available credit: 
  • 15.75 AAPA Category I CME
  • 15.75 ABPMR Accredited CME
  • 15.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 15.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 15.75 Attendance
Course opens: 
03/03/2026
Course expires: 
10/01/2026
Event starts: 
09/17/2026 - 7:00am EDT
Event ends: 
09/18/2026 - 5:00pm EDT
Cost:
$1.00
Add to calendar: 

PDF icon Program Agenda

 

www.lungconf.pitt.edu

University Club
Pittsburgh, PA
United States

Conflict of Interest Disclosure:

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.

Melanie Koenigshoff- Consultant with AstraZeneca & GSK. 
Frank Sciurba- Consultant with Sanofi/Regenron, AstraZeneca, GSK, Genentech, United Therapeutics, Uniquity. Grant/Research Support with Sanofi/Regeneron, AstraZeneca, Verona Pharma, Nuvaira, Gala Therapeutics, Pulmonx, NIH, AHRQ, COPD Foundation,  APREO, DevPro.
Ali Onder Yildirim- Consultant with RN-AI. Grant/Research support with Octapharma.
Maria Basil-Grant/Research Support with Bristol Myers Squibb. 
Jessica Bon- Speakers' Bureau with Sanofi. Consultant with Sanofi, Regeneron, AstraZeneca, & Pfizer.
Amit Gaggar- Stock options with Resbiotic and Alveolus Bio. Advisory board with 4DMT.
Michael Bradley Drummond- Consultant with Merck, Eli Lilly, GSK, AstraZeneca, Genentech, & Amgen. Grant/Research Support with Sanofi.
Mareike Lehmann- Grant/Research support with Boehringer Ingelheim.
Maria Rosa Faner Canet- Grant/Research support with AstraZeneca, Sanofi, Menarini. Consultant with AstraZeneca.
Irina Petrache- Consultant with Allinaire Therapeutics. Grant/Research Support with NHLBI, NIH, DOD grants. Scientific CoFounder with Allinaire Therapeutics.
Maor Sauler- Consultant with Sanofi/Regeneron & Genentech. Financial interest with Crosswalk health.
Nicola Hanania- Consultant with GSK, Sanofi, Regeneron, AstraZeneca, Connect Biopharma, Merck, Generate Biomedicine, & Genentech. Grant/research support with Sanofi, Regeneron, Genentech, AstraZeneca, & GSK.
Timothy Perkins- Consultant with Arrowhead Pharmaceuticals. Grant/research support with Arrowhead Pharmaceuticals.
Bradley Malin- Consultant with Amazon, Chryselys, GE, HealthVerity, IQVIA, Integral, Intuitive Surgical, Loppback, Natera, Sanofi-Aventis. Grant/Research support with Intuit.
Francesca Polverino- Speakers' Bureau with Pfizer, AZ, Genentech, Verona Merck, GSK. Grant/Reserach support with Sanofi Origins Grant.
Anuradha Ray- Speakers' Bureau with Santa Ana Bio. Consultant with Expedition Therapeutics. Grant/Research support with NCE.
Karina Serban- Grant/Research support with GondolaBio, Beam Therapeutics, Sanofi. Grifols- ALTA Grant review. 
Dirk-Jan Slebos - Consultant with Apreo, PulmonX, MorAir, Intuitive, Thirona. Grant/Research support with Apreo, PulmonX, Ryme, Pulmair, MorAir, Intuitive.
Raymond Wade- Consultant with AstraZeneca. 
Andrew Wilson- Consultant with Takeda.
Ali Önder Yildirim- Consultant with RN-AI and Octapharma.
George Washko- Grant/Research Support with NIH, United Therapeutics, 35Pharma. Consultant with 35Pharma, Argenx, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Genentech, GlaxoSmithKline, Insmed, Merck, Pulmonx, Rage Biotech, Regeneron, Sanofi. Stock options and stock publicly traded with Biogen.
Henrik Watz- Speakers' Bureau with AZ, BI, Chiesi, GSK, Merck, Sanofi, Veronapharma. Consultant with AZ, BU, Chiesi, GSK, Merck, Sanofi, Veronapharma, Novo Nordisk. Grant/Research support with AZ, BI, Chiesi, GSK, Merck, Sanofi, Veronapharma. Chair COPD Guideline German Respiratory Society; Chair disease area COPD of the German Center for Lung Research.
Sally Wenzel- Consultant with Chiesin, Johnson & Johnson. Grant/Research support with Regeneron. Stockholder publicly held with Aer Therapeutics.
Stephen Rennard- Consultant with Antidote, Arrowhead, CRISPR Therapeutics, Galvanize, Gondola, Lilly, Regeneron, RespirAI. Stock options with RespirAI and GreatPlainsBiometrix. Speakers' Bureau with Sanofi.
Yohannes Tesfaigzi- Grant/Research Support with NHLBI.


No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

 

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 15.75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Successful completion of this CME activity enables the learner to earn credit toward the CME requirements of the American Board of Physical Medicine and Rehabilitation’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABPMR credit

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 15.75 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 15.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.  

Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity. 
 

 

Available Credit

  • 15.75 AAPA Category I CME
  • 15.75 ABPMR Accredited CME
  • 15.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 15.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 15.75 Attendance

Grants:
AstraZeneca

Exhibitors:
Amgen
AstraZeneca
Baxter
GSK
Insmed, Inc.
Merck Pharmaceuticals
Novogene Corporation Inc
Pulmonx Corporation
Regeneron

Price

Cost:
$1.00
Please login or register to take this course.
 

     Before September 3rd   

September 3rd Onward

Physicians, Faculty, and Industry Professionals$300 $350
Nurses, PA's, RT’s, and other
Health Professionals		 $200$250
Fellows, Medical Residents, and Students $100 $150
Evening Program Registration  $75 (separate/in addition to conference fee)

 

All cancellations must be in writing and sent to us via U.S. mail (see contact information below) or email to [email protected]. No telephone cancellations will be accepted. Tuition for cancellations postmarked or date stamped before August 31 will be refunded in full in the form of the original payment method.  After August 31, a $50 administrative fee will be assessed and the remaining amount refunded. No refunds will be made after September 9. 

** Credit(s) must be claimed within 10 days after activity start date. Credit(s) will not be awarded after this date. **